Search Results 151-160 of 17086 for colorectal dysplasia

  1. A Study to Evaluate Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer - Mayo Clinic

    Giving duloxetine in patients undergoing treatment with oxaliplatin for colorectal cancer may help prevent peripheral neuropathy. Participation eligibility.

  2. MicroOrganoSphere Drug Screen Pilot Trial in Colorectal Cancer (CRC) - Mayo Clinic

    The primary objective of this study is to determine the feasibility of generating sufficient MicroOrganpSphere (MOS) from a biopsy of a patient's colorectal ...

  3. Mayo Clinic Minute: Colorectal cancer rates rising for younger people

    A new study has found that rates of colon and rectal cancers have declined overall since the 1980s, but researchers also made a puzzling discovery.

  4. Mayo Clinic Minute: What to know when colorectal cancer runs in the family VIDEO AUDIO Lisa Boardman, M.D. Gastroenterology Mayo

    "If you have a family history of colon cancer in, for instance, a parent, or a brother or sister, or even a child, you want to have your colon cancer ...

  5. A Study to Evaluate a Multi-target Stool DNA Test, Cologuard, for Colorectal Cancer (CRC) Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer - Mayo Clinic

    A Study to Evaluate a Multi-target Stool DNA Test, Cologuard, for Colorectal Cancer (CRC) Screening in Individuals Aged 45-49 and at Average Risk for ...

  6. DS-8201a in Human Epidermal Growth Factor Receptor2 (HER2)-Expressing Colorectal Cancer (DESTINY-CRC01) - Mayo Clinic

    The main objective of this study is to test the safety and effectiveness of DS-8201a for participants with HER2-expressing advanced colorectal cancer.

  7. Safety and Immunogenicity of PolyPEPI1018 Vaccine in the Treatment of Metastatic Colorectal Cancer (OBERTO) - Mayo Clinic

    Safety and Immunogenicity of PolyPEPI1018 Vaccine in the Treatment of Metastatic Colorectal Cancer (OBERTO) ... colorectal cancer. This study will also ...

  8. Mayo researchers examine risk factors and patient outcomes associated with colorectal cancer operations, identify benchmarks

    — About 20 percent of colorectal cancer patients have cancers that have spread (metastasized) beyond the colon at the time of their diagnosis. The liver is the ...

  9. Colorectal Cancer - eMERGE Genome Informed Risk Assessment - Mayo Clinic Research

    Colorectal Cancer. Monogenic risk. The risk of colorectal cancer is due to variants in any of these genes: EPCAM. MLH1. MSH2. MSH6. STK11. PMS2. For ...

  10. International Hip Dysplasia Registry (IHDR) with Follow-up to Skeletal Maturity - Mayo Clinic

    Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. ... International Hip Dysplasia ... dysplasia of a reduced hip, to an ...